{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:23Z","timestamp":1707525143648},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,13]]},"DOI":"10.7759\/cureus.41803","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T09:50:26Z","timestamp":1689241826000},"source":"Crossref","is-referenced-by-count":0,"title":["An Atypical Presentation of Chronic Inflammatory Myelin Degeneration in Neuromyelitis Optica (NMO)"],"prefix":"10.7759","author":[{"given":"Sai Vishnu Vardhan","family":"Allu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsh R","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneha","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ked","family":"Fortuzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misbahuddin","family":"Khaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti E","year":"2021","unstructured":"Carnero Contentti E, Correale J. Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies. J Neuroinflammation. 2021, 18:208. 10.1186\/s12974-021-02249-1","journal-title":"J Neuroinflammation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius S","year":"2020","unstructured":"Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B. Neuromyelitis optica. Nat Rev Dis Primers. 2020, 6:85. 10.1038\/s41572-020-0214-9","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"Trebst C","year":"2014","unstructured":"Trebst C, Jarius S, Berthele A, et al.. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol. 2014, 261:1-16. 10.1007\/s00415-013-7169-7","journal-title":"J Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318296ea08","article-title":"Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders","volume":"80","author":"Sato DK","year":"2013","unstructured":"Sato DK, Nakashima I, Takahashi T, et al.. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology. 2013, 80:2210-6. 10.1212\/WNL.0b013e318296ea08","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00035","article-title":"The detection of retina microvascular density in subclinical aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders","volume":"11","author":"Chen Y","year":"2020","unstructured":"Chen Y, Shi C, Zhou L, Huang S, Shen M, He Z. The detection of retina microvascular density in subclinical aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders. Front Neurol. 2020, 11:35. 10.3389\/fneur.2020.00035","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.06.060","article-title":"Natural history of the visual impairment of relapsing neuromyelitis optica","volume":"114","author":"Merle H","year":"2007","unstructured":"Merle H, Olindo S, Bonnan M, Donnio A, Richer R, Smadja D, Cabre P. Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology. 2007, 114:810-5. 10.1016\/j.ophtha.2006.06.060","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000246","article-title":"Teaching neuroimages: MRI in advanced neuromyelitis optica","volume":"82","author":"Braksick SA","year":"2014","unstructured":"Braksick SA, Cutsforth-Gregory JK, Black DF, Weinshenker BG, Pittock SJ, Kantarci OH. Teaching neuroimages: MRI in advanced neuromyelitis optica. Neurology. 2014, 82:e101-2. 10.1212\/WNL.0000000000000246","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.53347\/rID-38418","article-title":"Normal cervical spine MRI","volume":"38418","author":"Di Muzio B","year":"2015","unstructured":"Di Muzio B. Normal cervical spine MRI. Radiopaedia. 2015, 38418:10.53347\/rID-38418","journal-title":"Radiopaedia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30392-6","article-title":"New therapies for neuromyelitis optica spectrum disorder","volume":"20","author":"Levy M","year":"2021","unstructured":"Levy M, Fujihara K, and Palace J. New therapies for neuromyelitis optica spectrum disorder. Lancet Neurol. 2021, 20:60-7. 10.1016\/S1474-4422(20)30392-6","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040133","article-title":"Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica","volume":"4","author":"Paul F","year":"2007","unstructured":"Paul F, Jarius S, Aktas O, et al.. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med. 2007, 4:e133. 10.1371\/journal.pmed.0040133","journal-title":"PLoS Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos MC","year":"2012","unstructured":"Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol. 2012, 11:535-44. 10.1016\/S1474-4422(12)70133-3","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000742","article-title":"Neuromyelitis optica spectrum disorder and other non-multiple sclerosis central nervous system inflammatory diseases","volume":"25","author":"Flanagan EP","year":"2019","unstructured":"Flanagan EP. Neuromyelitis optica spectrum disorder and other non-multiple sclerosis central nervous system inflammatory diseases. Continuum (Minneap Minn). 2019, 25:815-44. 10.1212\/CON.0000000000000742","journal-title":"Continuum (Minneap Minn)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102399","article-title":"Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica","volume":"45","author":"Ciotti JR","year":"2020","unstructured":"Ciotti JR, Eby NS, Wu GF, Naismith RT, Chahin S, Cross AH. Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica. Mult Scler Relat Disord. 2020, 45:102399. 10.1016\/j.msard.2020.102399","journal-title":"Mult Scler Relat Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.599042","article-title":"Deep learning-based method to differentiate neuromyelitis optica spectrum disorder from multiple sclerosis","volume":"11","author":"Kim H","year":"2020","unstructured":"Kim H, Lee Y, Kim YH, et al.. Deep learning-based method to differentiate neuromyelitis optica spectrum disorder from multiple sclerosis. Front Neurol. 2020, 11:599042. 10.3389\/fneur.2020.599042","journal-title":"Front Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/01.CON.0000433289.38339.a2","article-title":"Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica","volume":"19","author":"Wingerchuk DM","year":"2013","unstructured":"Wingerchuk DM, Weinshenker BG. Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica. Continuum (Minneap Minn). 2013, 19:944-67. 10.1212\/01.CON.0000433289.38339.a2","journal-title":"Continuum (Minneap Minn)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/cen3.12394","article-title":"Neuromyelitis optica spectrum disorders: emerging therapies","volume":"8","author":"Araki M","year":"2017","unstructured":"Araki M, Yamamura T. Neuromyelitis optica spectrum disorders: emerging therapies. Clin Exp Neuroimmunol. 2017, 8:107-16. 10.1111\/cen3.12394","journal-title":"Clin Exp Neuroimmunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-302310","article-title":"Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders","volume":"84","author":"Jacob A","year":"2013","unstructured":"Jacob A, McKeon A, Nakashima I, Sato DK, Elsone L, Fujihara K, de Seze J. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. J Neurol Neurosurg Psychiatry. 2013, 84:922-30. 10.1136\/jnnp-2012-302310","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk DM","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999, 53:1107-14. 10.1212\/wnl.53.5.1107","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/1352458510382324","article-title":"Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes","volume":"16","author":"Parratt JD","year":"2010","unstructured":"Parratt JD, Prineas JW. Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes. Mult Scler. 2010, 16:1156-72. 10.1177\/1352458510382324","journal-title":"Mult Scler"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk DM","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, et al.. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015, 85:177-89. 10.1212\/WNL.0000000000001729","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/161250-an-atypical-presentation-of-chronic-inflammatory-myelin-degeneration-in-neuromyelitis-optica-nmo","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:40Z","timestamp":1707509020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/161250-an-atypical-presentation-of-chronic-inflammatory-myelin-degeneration-in-neuromyelitis-optica-nmo"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.41803","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,13]]}}}